TEK and cancer: The novel proteins targeting the Tie2–αvβ3 integrin axis could find clinical application as therapeutics or imaging agents and could also constitute new tools for studying molecular mechanisms and cell signaling pathways involving Tie2 and αvβ3 integrin, which mediate cancer metastasis, angiogenesis, and other important biological processes.